Review
Accepted on 05 Nov 2025
CXCR4-Targeted Therapy in Lung Cancer: Plerixafor as a Promising Antimetastatic Agent
in Pharmacology of Anti-Cancer Drugs
- 179 views
Review
Accepted on 05 Nov 2025
in Pharmacology of Anti-Cancer Drugs
Original Research
Accepted on 05 Nov 2025
in Nuclear Medicine
Mini Review
Accepted on 05 Nov 2025
in Inflammation
Systematic Review
Accepted on 05 Nov 2025
in Pest Management
Systematic Review
Accepted on 05 Nov 2025
in Hypertension
Original Research
Accepted on 05 Nov 2025
in Plant Bioinformatics
Review
Accepted on 05 Nov 2025
in Stroke
Review
Accepted on 05 Nov 2025
in Non-Neuronal Cells
Original Research
Accepted on 05 Nov 2025
in Motor Neuroscience
Clinical Trial
Accepted on 05 Nov 2025
in Clinical Neuroimaging
Original Research
Accepted on 05 Nov 2025
in Plant Abiotic Stress
Original Research
Accepted on 05 Nov 2025
in Neurotrauma
Systematic Review
Published on 05 Nov 2025
in Surgical Oncology
Original Research
Published on 05 Nov 2025
in Environmental Health and Exposome
Review
Published on 05 Nov 2025
in Membrane Modules and Processes
Review
Published on 05 Nov 2025
in Virus and Host